<?xml version="1.0" encoding="UTF-8"?>
<p id="Par22">Mutations in 
 <italic>VPS35</italic> cause autosomal PD with a phenotype that is clinically indistinguishable from idiopathic PD.
 <sup>
  <xref ref-type="bibr" rid="CR52">52</xref>,
  <xref ref-type="bibr" rid="CR53">53</xref>
 </sup> We identified a total of five articles, all describing PD-patients with the D620N 
 <italic>VPS35</italic> mutation treated with DBS. As part of screening efforts following the identification of the gene, two mutation carriers treated with DBS were reported, one with a good motor outcome
 <sup>
  <xref ref-type="bibr" rid="CR54">54</xref>
 </sup>, the other implanted at high age with a small benefit, yet complicated by dysarthria.
 <sup>
  <xref ref-type="bibr" rid="CR55">55</xref>
 </sup> Two publications have followed-up kindreds included in one of the studies that originally linked the gene to PD, reporting DBS treatment in one US
 <sup>
  <xref ref-type="bibr" rid="CR56">56</xref>
 </sup> and two Swiss patients
 <sup>
  <xref ref-type="bibr" rid="CR57">57</xref>
 </sup> with a good response, sustained for up to eight years postoperatively. Similarly, an excellent long-term motor response to DBS was described in a Taiwanese patient carrying the 
 <italic>VPS35</italic> D620N mutation.
 <sup>
  <xref ref-type="bibr" rid="CR58">58</xref>
 </sup>
</p>
